Two Sigma Investments, LP Cellectar Biosciences, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.6 - $7.8 $299,395 - $507,670	-65,086 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.1 - $10.2 $112,593 - $188,271	18,458 Added 39.59%	65,086 $43,000
Q3 2021 Nov 15, 2021	SELL	$8.2 - $12.4 $1.72 Million - $2.61 Million	-210,190 Reduced 81.84%	46,628 $43,000
Q2 2021 Aug 16, 2021	SELL	$11.8 - $18.2 $4.8 Million - $7.4 Million	-406,383 Reduced 61.28%	256,818 $306,000
Q1 2021 May 17, 2021	BUY	$15.2 - $25.0 $9.36 Million - $15.4 Million	616,026 Added 1305.83%	663,201 $1.07 Million
Q4 2020 Feb 16, 2021	BUY	$11.2 - $27.7 $528,360 - $1.31 Million	47,175 New	47,175 $98,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $9.17M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.